Sign In

Login

Password

Forgot Password ? Sign Up

Indacaterol (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Indacaterol" in German language version.

refsWebsite
Global rank German rank
4doi.org
2nd place
3rd place
4nih.gov
4th place
7th place
1europa.eu
68th place
29th place
1ersjournals.com
low place
low place
1akdae.de
low place
1,853rd place
1aspetjournals.org
6,663rd place
4,062nd place

akdae.de (Global: low place; German: 1,853rd place)

aspetjournals.org (Global: 6,663rd place; German: 4,062nd place)

jpet.aspetjournals.org

  • Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A: In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. In: J Pharmacol Exp Ther. 317. Jahrgang, Nr. 2, Mai 2006, S. 762–770, doi:10.1124/jpet.105.098251, PMID 16434564 (aspetjournals.org).

doi.org (Global: 2nd place; German: 3rd place)

  • Beeh KM, Derom E, Kanniess F, Cameron R, Higgins M, van As A: Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma. In: Eur. Respir. J. 29. Jahrgang, Nr. 5, Mai 2007, S. 871–8, doi:10.1183/09031936.00060006, PMID 17251236 (ersjournals.com).
  • Beier J, Beeh KM, Brookman L, Peachey G, Hmissi A, Pascoe S: Bronchodilator effects of indacaterol and formoterol in patients with COPD. In: Pulm Pharmacol Ther. 22. Jahrgang, Nr. 6, Dezember 2009, S. 492–496, doi:10.1016/j.pupt.2009.05.001, PMID 19465142.
  • Mark Kagan, Jeremy Dain, Lana Peng, Christine Reynolds: Metabolism and pharmacokinetics of indacaterol in humans. In: Drug Metabolism and Disposition: The Biological Fate of Chemicals. Band 40, Nr. 9, September 2012, S. 1712–1722, doi:10.1124/dmd.112.046151, PMID 22648561.
  • Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A: In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. In: J Pharmacol Exp Ther. 317. Jahrgang, Nr. 2, Mai 2006, S. 762–770, doi:10.1124/jpet.105.098251, PMID 16434564 (aspetjournals.org).

ersjournals.com (Global: low place; German: low place)

erj.ersjournals.com

  • Beeh KM, Derom E, Kanniess F, Cameron R, Higgins M, van As A: Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma. In: Eur. Respir. J. 29. Jahrgang, Nr. 5, Mai 2007, S. 871–8, doi:10.1183/09031936.00060006, PMID 17251236 (ersjournals.com).

europa.eu (Global: 68th place; German: 29th place)

echa.europa.eu

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • Beeh KM, Derom E, Kanniess F, Cameron R, Higgins M, van As A: Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma. In: Eur. Respir. J. 29. Jahrgang, Nr. 5, Mai 2007, S. 871–8, doi:10.1183/09031936.00060006, PMID 17251236 (ersjournals.com).
  • Beier J, Beeh KM, Brookman L, Peachey G, Hmissi A, Pascoe S: Bronchodilator effects of indacaterol and formoterol in patients with COPD. In: Pulm Pharmacol Ther. 22. Jahrgang, Nr. 6, Dezember 2009, S. 492–496, doi:10.1016/j.pupt.2009.05.001, PMID 19465142.
  • Mark Kagan, Jeremy Dain, Lana Peng, Christine Reynolds: Metabolism and pharmacokinetics of indacaterol in humans. In: Drug Metabolism and Disposition: The Biological Fate of Chemicals. Band 40, Nr. 9, September 2012, S. 1712–1722, doi:10.1124/dmd.112.046151, PMID 22648561.
  • Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A: In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. In: J Pharmacol Exp Ther. 317. Jahrgang, Nr. 2, Mai 2006, S. 762–770, doi:10.1124/jpet.105.098251, PMID 16434564 (aspetjournals.org).